Recent Updates
Recently added Catalysts
PFSA Positive Sentiment Score: 70/100

Profusa Invests Additional $1 Million in Digital Treasury Assets

Key Takeaway: Profusa, Inc. has announced an additional $1 million investment in digital treasury assets as part of its strategy to hedge against macroeconomic uncertainties. This investment follows a prior $1 million tranche, totaling $2 million in collaborations with Ascent Partners Fund. The company aims to sustain capital for developing its AI-driven Lumee platform, despite potential risks highlighted in forward-looking statements regarding future performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Profusa's additional investment demonstrates confidence in their digital treasury strategy.
  • The company is proactively managing its resources to support their Lumee platform technology.
  • Collaboration with Ascent Partners Fund strengthens their capital-efficient investment approach.

CONCERNS & RISKS

  • Forward-looking statements carry inherent risks and uncertainties that may impact future performance.
  • Market volatility and macroeconomic factors could affect the success of their digital asset strategy.

Full Press Release Details

Invests Additional $1 Million in Digital Treasury Assets
Calif, October 7, 2025 (GLOBE NEWSWIRE) - Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a
commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual's
biochemistry, announces its second $1 million investment in digital treasury assets to hedge against macroeconomic uncertainties, in
line with the Company's treasury management strategy.
believe the continued execution of our digital asset strategy helps ensure that we are prudently managing our resources to continue to
support both our commercial and development plans for our Lumee platform technology. Our digital treasury strategy is designed to facilitate
that we maintain sufficient capital to provide the best-in-class, AI-driven digital health platform for the benefit of chronic disease
and health and wellness management. We continue to collaborate with Ascent Partners Fund, which has now raised our second tranche for
a total of $2 million in investments, to establish a low cost, capital efficient, best of breed Bitcoin treasury strategy which reflects
our strong conviction that Bitcoin is the digital store of value for the future. We believe it will provide firm foundation as we progress
our commercial and clinical programs," said Ben Hwang, Ph.D., Profusa's Chairman and CEO.
in Berkeley, Calif., Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management
team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously
transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and
its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians
can trust and rely on.
"PROFUSA" and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China,
Japan, South Korea and Australia.
more information, visit https://profusa.com.
Note Regarding Forward-Looking Statements
statements in this press release (this "Press Release") may be considered "forward-looking statements" within
the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking
statements generally relate to future events or future financial or operating performance of Profusa. In some cases, you can identify
forward-looking statements by terminology such as "anticipate," "believe," "continue," "could,"
"estimate," "expect," "forecast," "future," "intend," "may,"
"might," "plan," "possible," "potential," "predict," "project,"
"propose," "seek," "should," "strive," "will," or "would" or
the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties,
and other factors which may be beyond the control of Profusa and could cause actual results to differ materially from those expressed
or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while
considered reasonable by Profusa and its management are inherently uncertain. Profusa cautions you that these statements are based on
a combination of facts and factors currently known and projections of the future, which are inherently uncertain. There are risks and
uncertainties described in the definitive proxy/final prospectus relating to the business combination, which has been filed with the
SEC, and in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other important risks
and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.

Frequently Asked Questions

What is Profusa's recent investment in digital treasury assets?

Profusa has invested an additional $1 million in digital treasury assets to manage macroeconomic uncertainties.

What technology does Profusa specialize in?

Profusa develops next-generation tissue-integrated sensors for continuous biochemistry monitoring.

How much total investment has Profusa made in digital assets?

Profusa has invested a total of $2 million in digital assets through collaboration with Ascent Partners Fund.

What is the focus of Profusa's AI-driven platform?

The platform aims to enhance chronic disease management and health and wellness monitoring.

What belief does Profusa hold regarding Bitcoin?

Profusa believes Bitcoin is the future digital store of value that supports its treasury strategy.

Last updated: Oct 7, 2025